BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32333005)

  • 1. Plasmapheresis in recalcitrant anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive immune-mediated necrotizing myopathy: a case report.
    Lötscher F; Ruffer N; Horn M; Villiger P
    Rheumatology (Oxford); 2020 Nov; 59(11):e82-e84. PubMed ID: 32333005
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibody-positive necrotizing autoimmune myopathy with dermatomyositis-like eruption.
    Parikh P; Tavee J; Soltanzadeh P; Mammen AL; McKeever P; Li Y
    Muscle Nerve; 2018 Jun; 57(6):E135-E136. PubMed ID: 29346706
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive paraneoplastic necrotizing myopathy associated with advanced gastric cancer that responded to intravenous immunoglobulin therapy].
    Yamaguchi T; Matsunaga A; Ikawa M; Shirafuji N; Nishino I; Hamano T
    Rinsho Shinkeigaku; 2017 Mar; 57(3):118-123. PubMed ID: 28228619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
    Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
    Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble.
    Tanboon J; Sanmaneechai O; Charuvanij S; Sangruchi T; Galindo-Feria AS; Lundberg IE; Ohnuki Y; Shiina T; Suzuki S; Nishino I
    Neuromuscul Disord; 2019 Jul; 29(7):543-548. PubMed ID: 31204143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-HMG-CoA reductase necrotizing myopathy: A report of 4 cases].
    Marti J; Kolev I; Lorleac'h A; Besnard S; Pihan M; Marcorelles P
    Rev Med Interne; 2017 Apr; 38(4):228-234. PubMed ID: 27876175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
    Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
    J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
    Werner JL; Christopher-Stine L; Ghazarian SR; Pak KS; Kus JE; Daya NR; Lloyd TE; Mammen AL
    Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and outcomes in necrotising autoimmune myopathy: An Australian perspective.
    Ashton C; Junckerstorff R; Bundell C; Hollingsworth P; Needham M
    Neuromuscul Disord; 2016 Nov; 26(11):734-740. PubMed ID: 27665513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.
    Drouot L; Allenbach Y; Jouen F; Charuel JL; Martinet J; Meyer A; Hinschberger O; Bader-Meunier B; Kone-Paut I; Campana-Salort E; Eymard B; Tournadre A; Musset L; Sibilia J; Marie I; Benveniste O; Boyer O;
    Arthritis Res Ther; 2014 Feb; 16(1):R39. PubMed ID: 24484965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous symptomatic improvement in a pediatric patient with anti-3-hydroxy-3-methylglutraryl-coenzyme A reductase myopathy.
    Suárez B; Jofré J; Lozano-Arango A; Ortega X; Diaz J; Calcagno G; Bevilacqua JA; Castiglioni C
    Neuromuscul Disord; 2020 Jun; 30(6):503-509. PubMed ID: 32518057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying statin-associated autoimmune necrotizing myopathy.
    Albayda J; Christopher-Stine L
    Cleve Clin J Med; 2014 Dec; 81(12):736-41. PubMed ID: 25452351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autopsy case of anti-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy with involvement of the heart, lungs and respiratory muscles.
    Fujikawa H; Minoda M; Owada Y; Watanabe K
    Rheumatology (Oxford); 2021 Oct; 60(10):e348-e350. PubMed ID: 33764374
    [No Abstract]   [Full Text] [Related]  

  • 14. Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects.
    Mammen AL; Pak K; Williams EK; Brisson D; Coresh J; Selvin E; Gaudet D
    Arthritis Care Res (Hoboken); 2012 Feb; 64(2):269-72. PubMed ID: 21972203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Childhood-onset anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) necrotizing myopathy needs to be distinguished from muscular dystrophy: A case study].
    Hama Y; Mori-Yoshimura M; Komaki H; Suzuki S; Kohsaka H; Nishino I; Takahashi Y
    Rinsho Shinkeigaku; 2017 Oct; 57(10):567-572. PubMed ID: 28966227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
    Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y
    Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When Statins Cause an Autoimmune Response: A Report of a Severe Case of Rhabdomyolysis.
    Hasan S; Abushahin A; Prayson R; Kilani A
    Am J Med; 2020 Jan; 133(1):50-51. PubMed ID: 31247184
    [No Abstract]   [Full Text] [Related]  

  • 18. Paraneoplastic Anti-3-hydroxy-3-methylglutary-coenzyme A Reductase Antibody-positive Immune-mediated Necrotizing Myopathy in a Patient with Uterine Cancer.
    Mizuma A; Kouchi M; Netsu S; Yutani S; Kitao R; Suzuki S; Murata K; Nagata E; Takizawa S
    Intern Med; 2017; 56(14):1915-1918. PubMed ID: 28717093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy.
    Kassardjian CD; Lennon VA; Alfugham NB; Mahler M; Milone M
    JAMA Neurol; 2015 Sep; 72(9):996-1003. PubMed ID: 26192196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience.
    Klein M; Mann H; Pleštilová L; Zámečník J; Betteridge Z; McHugh N; Vencovský J
    Rheumatology (Oxford); 2015 Nov; 54(11):2010-4. PubMed ID: 26109604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.